000062868 001__ 62868
000062868 005__ 20200402210514.0
000062868 037__ $$aPreJuSER-62868
000062868 1001_ $$0P:(DE-Juel1)VDB65869$$aFunke, S. A.$$b0$$uFZJ
000062868 1112_ $$cKeystone, Colo.$$d2008-03-24
000062868 245__ $$aDrastic Alzheimer's disease related Aß plaque reduction in transgenic mice by an Aß specific ligand
000062868 260__ $$c2008
000062868 29510 $$aKeystone Symposium on Alzheimer's Disease
000062868 3367_ $$0PUB:(DE-HGF)24$$2PUB:(DE-HGF)$$aPoster
000062868 3367_ $$033$$2EndNote$$aConference Paper
000062868 3367_ $$2DataCite$$aOutput Types/Conference Poster
000062868 3367_ $$2DRIVER$$aconferenceObject
000062868 3367_ $$2ORCID$$aCONFERENCE_POSTER
000062868 3367_ $$2BibTeX$$aINPROCEEDINGS
000062868 500__ $$aRecord converted from VDB: 12.11.2012
000062868 536__ $$0G:(DE-Juel1)FUEK409$$2G:(DE-HGF)$$aFunktion und Dysfunktion des Nervensystems$$cP33$$x0
000062868 7001_ $$0P:(DE-HGF)0$$avan Groen, Th.$$b1
000062868 7001_ $$0P:(DE-Juel1)VDB15437$$aWiesehan, K.$$b2$$uFZJ
000062868 7001_ $$0P:(DE-HGF)0$$aKadish, I.$$b3
000062868 7001_ $$0P:(DE-Juel1)VDB72731$$aNagel-Steger, L.$$b4$$uFZJ
000062868 7001_ $$0P:(DE-Juel1)VDB65461$$aBartnik, D.$$b5$$uFZJ
000062868 7001_ $$0P:(DE-Juel1)132029$$aWillbold, D.$$b6$$uFZJ
000062868 909CO $$ooai:juser.fz-juelich.de:62868$$pVDB
000062868 9131_ $$0G:(DE-Juel1)FUEK409$$bGesundheit$$kP33$$lFunktion und Dysfunktion des Nervensystems$$vFunktion und Dysfunktion des Nervensystems$$x0
000062868 9141_ $$y2008
000062868 9201_ $$0I:(DE-Juel1)VDB805$$d31.12.2008$$gINB$$kINB-2$$lMolekulare Biophysik$$x0
000062868 970__ $$aVDB:(DE-Juel1)99750
000062868 980__ $$aVDB
000062868 980__ $$aConvertedRecord
000062868 980__ $$aposter
000062868 980__ $$aI:(DE-Juel1)ISB-2-20090406
000062868 980__ $$aUNRESTRICTED
000062868 980__ $$aI:(DE-Juel1)ICS-6-20110106
000062868 981__ $$aI:(DE-Juel1)IBI-7-20200312
000062868 981__ $$aI:(DE-Juel1)ISB-2-20090406
000062868 981__ $$aI:(DE-Juel1)ICS-6-20110106